1. Brower AC, Allman RM. 1981; The neuropathic joint: a neurovascular bone disorder. Radiol Clin North Am. 19:571–80. DOI:
10.1016/S0033-8389(22)01344-6.
2. Waibel FWA, Böni T. 2022; Nonoperative treatment of Charcot neuro-osteoarthropathy. Foot Ankle Clin. 27:595–616. doi: 10.1016/j.fcl.2022.05.002. DOI:
10.1016/j.fcl.2022.05.002.
3. Pinzur MS. 1999; Benchmark analysis of diabetic patients with neuropathic (Charcot) foot deformity. Foot Ankle Int. 20:564–7. doi: 10.1177/107110079902000905. DOI:
10.1177/107110079902000905.
4. Bajuri MY, Ong SL, Das S, Mohamed IN. 2022; Charcot neuroarthropathy: current surgical management and update. A systematic review. Front Surg. 9:820826. doi: 10.3389/fsurg.2022.820826. DOI:
10.3389/fsurg.2022.820826.
5. Lowery NJ, Woods JB, Armstrong DG, Wukich DK. 2012; Surgical management of Charcot neuroarthropathy of the foot and ankle: a systematic review. Foot Ankle Int. 33:113–21. doi: 10.3113/FAI.2012.0113. DOI:
10.3113/FAI.2012.0113.
6. Jensen TS, Karlsson P, Gylfadottir SS, Andersen ST, Bennett DL, Tankisi H, et al. 2021; Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain. 144:1632–45. doi: 10.1093/brain/awab079. DOI:
10.1093/brain/awab079.
7. Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, et al. 2000; Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology. 141:3956–64. doi: 10.1210/endo.141.11.7739. DOI:
10.1210/endo.141.11.7739.
8. Grear BJ, Rabinovich A, Brodsky JW. 2013; Charcot arthropathy of the foot and ankle associated with rheumatoid arthritis. Foot Ankle Int. 34:1541–7. doi: 10.1177/1071100713500490. DOI:
10.1177/1071100713500490.